[Effect of the new drug provisions on the drug treatment of narcolepsy].
Mayer
G
G
Hephata Klinik, Schwalmstadt-Treysa. geert.mayer@hephata.com
D000662:Amphetamines / Q000627:therapeutic use*; D000928:Antidepressive Agents / Q000627:therapeutic use; D002385:Cataplexy / Q000188:drug therapy; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D018491:Dopamine Agonists / Q000627:therapeutic use*; D005858:Germany; D019983:Guideline Adherence; D006212:Hallucinations / Q000188:drug therapy; D006801:Humans; D007880:Legislation, Drug; D009290:Narcolepsy / Q000188:drug therapy*; D020188:Sleep Paralysis / Q000188:drug therapy
D000662:Amphetamines; D000928:Antidepressive Agents; D000697:Central Nervous System Stimulants; D018491:Dopamine Agonists